FDA Orange Book

Is there a generic for Beqalzi?

Beqalzi contains sonrotoclax. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Beqalzi (sonrotoclax). The Orange Book shows its last listed patent expires April 29, 2039 and its last listed exclusivity ends May 13, 2031.

Run it in Rivvi

Map Beqalzi and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Beqalzi products in the Orange Book

Beqalzi products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
tablet, oral1MGMarketed (Rx)None0None
tablet, oral20MGMarketed (Rx)None0None
tablet, oral5MGMarketed (Rx)None0None
tablet, oral80MGMarketed (Rx)None0None

NDA 220711, held by BEONE MEDICINES USA INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Beqalzi patents

Patents listed for Beqalzi
PatentExpiresCoversUse codeNDA
11420968April 29, 2039Drug substance, Drug productNone220711

Beqalzi exclusivity

Exclusivity listed for Beqalzi
CodeMeaningExpiresNDA
NCENew chemical entityMay 13, 2031220711

Beqalzi NDC codes

Questions

Is there a generic for Beqalzi?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Beqalzi (sonrotoclax). The Orange Book shows its last listed patent expires April 29, 2039 and its last listed exclusivity ends May 13, 2031.

What is the generic name for Beqalzi?

The active ingredient in Beqalzi is sonrotoclax, per the FDA Orange Book.

When does the Beqalzi patent expire?

The last patent listed for Beqalzi in the Orange Book expires April 29, 2039. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Beqalzi and Sonrotoclax

Try it on your own data today.

Free to start. Most teams are using it the same day.